首页> 美国卫生研究院文献>other >Ochratoxin A and human health risk: A review of the evidence
【2h】

Ochratoxin A and human health risk: A review of the evidence

机译:ch曲毒素A与人类健康风险:证据回顾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ochratoxin A (OTA) is a mycotoxin produced by several fungal species including Aspergillus ochraceus, A. carbonarius, A. niger and Penicillium verrucosum. OTA causes nephrotoxicity and renal tumors in a variety of animal species; however, human health effects are less well-characterized. Various studies have linked OTA exposure with the human diseases Balkan endemic nephropathy (BEN) and chronic interstitial nephropathy (CIN), as well as other renal diseases. This study reviews the epidemiological literature on OTA exposure and adverse health effects in different populations worldwide, and assesses the potential human health risks of OTA exposure. Epidemiological studies identified in a systematic review were used to calculate unadjusted odds ratios for OTA associated with various health endpoints. With one exception, there appears to be no statistically significant evidence for human health risks associated with OTA exposure. One Egyptian study showed a significantly higher risk of nephritic syndrome in those with very high urinary OTA levels compared with relatively unexposed individuals; however, other potential risk factors were not controlled for in the study. Larger cohort or case-control studies are needed in the future to better establish potential OTA-related human health effects, and further duplicate-diet studies are needed to validate biomarkers of OTA exposure in humans.
机译:ch曲霉毒素A(OTA)是由几种真菌物种产生的霉菌毒素,其中包括曲霉,碳曲霉,黑曲霉和疣状青霉。 OTA会引起多种动物的肾毒性和肾肿瘤。然而,对人类健康的影响却鲜为人知。各种研究已将OTA暴露与人类疾病巴尔干地方性肾病(BEN)和慢性间质性肾病(CIN)以及其他肾脏疾病联系起来。这项研究回顾了有关全球不同人群中OTA暴露和不良健康影响的流行病学文献,并评估了OTA暴露对人类健康的潜在风险。系统评价中确定的流行病学研究用于计算与各种健康终点相关的OTA的未调整比值比。除一个例外,似乎没有统计学上显着的证据表明与OTA接触有关的人类健康风险。一项埃及研究表明,与相对未暴露的个人相比,尿中OTA水平很高的人有较高的肾病综合征风险。但是,其他潜在风险因素并未在研究中得到控制。将来需要进行更大的队列研究或病例对照研究,以更好地确定潜在的与OTA相关的人类健康影响,还需要进一步的重复饮食研究来验证人类OTA暴露的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号